Valuation: MRI Interventions Inc

Market Cap 517M 444M 417M 381M 718M 49.34B 722M 4.93B 1.91B 24.89B 1.94B 1.9B 82.45B P/E 2026 *
-12.8x
P/E 2027 * -15.3x
Enterprise Value 517M 444M 417M 381M 718M 49.34B 722M 4.93B 1.91B 24.89B 1.94B 1.9B 82.45B EV / Sales 2026 *
10.6x
EV / Sales 2027 * 9.07x
Free-Float
94.56%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 07/11/2017
Director of Finance/CFO 41 01/01/2021
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 68 10/03/2014
Chairman 80 04/02/2021
Director/Board Member 49 07/11/2017
Change 5-day change 1-year change 3-year change Capi.($)
+24.88%-8.05% - - 517M
+0.96%+3.24%+29.67%+16.19% 232B
+0.06%+1.88%+4.48%-17.60% 152B
-0.31%-7.01%-22.01%+22.68% 131B
-2.77%-7.40%-54.73%-10.47% 72.26B
-1.11%-1.80%-16.89%-14.19% 51.57B
+0.47%-1.12%+12.27%+20.01% 52.38B
-0.91%-1.22%+29.77%+28.02% 43.71B
-0.36%-0.60%+39.58%+46.86% 40.72B
-0.26%+9.83%+128.05%+42.32% 33.97B
Average +2.11%+3.90%+16.69%+14.87% 90.01B
Weighted average by Cap. -0.10%+3.71%+9.58%+10.12%

Financials

2026 *2027 *
Net sales 48.9M 41.97M 39.39M 35.98M 67.9M 4.66B 68.23M 466M 181M 2.35B 184M 180M 7.79B 57.07M 48.98M 45.97M 41.99M 79.24M 5.44B 79.63M 544M 211M 2.75B 214M 210M 9.09B
Net income -39.97M -34.3M -32.2M -29.41M -55.5M -3.81B -55.77M -381M -148M -1.92B -150M -147M -6.37B -35.23M -30.24M -28.38M -25.92M -48.93M -3.36B -49.16M -336M -130M -1.7B -132M -129M -5.62B
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-